Skip to main content

PT-141 Applications

Meaning

The clinical use of the synthetic peptide PT-141 (Bremelanotide) as a therapeutic agent, primarily indicated for the treatment of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This medication is distinct from traditional sexual dysfunction treatments that act on the vascular system because it acts centrally to increase sexual desire and arousal. Its application involves self-administered subcutaneous injection, representing a novel pharmacological approach to addressing the neurobiological aspects of sexual health and well-being.